Gene Morse
PharmD, FCCP, BCPS
Position: Advisory Board Member
Gene Morse has been actively involved in drug development research since the introduction of antiretrovirals for HIV in 1986.
Personal Biography
Experience & Career
The TPRC program conducts innovative research and fosters collaborations in new areas of HIV and hepatitis C virus drug development and therapeutics implementation research including pre-clinical evaluation, phase I, II, and III FDA trials, ongoing post-approval Phase IV research, nanomedicine, health information technology, and medication management. The TPRC is an internationally recognized leader in antiviral pharmacology and has an expanding global health program. UB’s HIV and HCV Clinical Pharmacology Laboratory conducts innovative HIV and HCV clinical and translational research; investigates novel biomatrices and compartments for the measurement of antiviral activity; integrates pharmacokinetics and pharmacodynamics with human and viral genomics and proteomics to facilitate and accelerate drug development research; and, promotes capacity building to train translational scientists and build global research infrastructure for antivirals and associated co-infections.